Speaker Profile

M.D., R&D Program Head, Human Genetics and Infectious Diseases, Bio-Rad Laboratories

Biography
Monica Herrera is responsible for assay development of clinically relevant screening, diagnosis, and monitoring applications using Bio-Rad's digital droplet PCR technology, within the human genetics and infectious disease markets. Most recently, she launched the SARS-CoV-2 ddPCR Kit, granted EUA by FDA in May 2020 and is the focus of various clinical research collaborations due to its high sensitivity and quantitative nature. Previously, while at Roche Diagnostics, she led the development of CINtec PLUS Cytology, a first-of-its-kind immunocytochemistry duplex assay for cervical cancer screening, now recognized as part of the testing algorithm in the US and other geographies. Monica also served as the Lifecycle Project Leader for the Harmony NIPT business area, bringing that portfolio onto next-generation platforms. Monica is an accomplished Diagnostic Development professional with a scientific and medical background spanning more than 15 years; she is passionate about bringing innovative and patient-centric solutions into the clinical space.


×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by AUG. 1ST

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required